Atlas FDA

Elecsys HBsAg II

FDA premarket approval P160019/S006 · decided 2017-12-20

Approval details

PMA number
P160019
Supplement
S006
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Elecsys HBsAg II
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Roche Diagnostics, Inc.
Date received
2017-10-11
Decision date
2017-12-20
Days to decision
70 days
Decision code
APPR
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Indianapolis, IN
Statement
Approval for implementation of system software 06-04 on the cobas e 602 to address a software limitation

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.